Key facts
- Scanvio’s last known valuation is $11.6M (Jun 2025).
- It has raised $3.4M; the latest was Early Stage VC ($3.3M) in Jun 2025.
- Notable investors include Venture Kick, Kickfund, Superangels, S2S Ventures, EuroUS Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Scanvio
- ·The full record, as it builds
Funding rounds
No funding rounds for Scanvio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Scanvio
Developer of AI-augmented ultrasound software designed to improve the lives of women suffering from endometriosis. The company's software specializes in the ultrasound-based diagnosis of endometriosis, medical technology, and machine learning, enabling doctors to offer earlier diagnoses with AI-assisted ultrasound at the first gynecologic examination.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Founded
- 2023
- Employees
- 9
- Website
- scanvio.com/
- Ownership
- Privately Held (backing)
Scanvio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Scanvio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Scanvio in its N-PORT filings yet. We sweep new filings monthly.